Back to
MACQUARIE GROUP LTD
IOVA
Showing 4 of 24 quarters
Position history for
MACQUARIE GROUP LTD's holdings in IOVANCE BIOTHERAPEUTICS INC
No. Macquarie Group exited its IOVA (Iovance Biotherapeutics) position in Q2 2025. Its Q1 2025 13F listed 4,791,235 shares worth $16M. Macquarie Group first reported IOVA in Q1 2019 and held it in 21 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$30M
Total Shares Change
-3.2M
Quarter-by-Quarter History